Glucose Hexokinase (Liquid) Reagent For the in vitro quantitative determination of Glucose in serum.
Published December 24, 2014 · Recall initiated: October 23, 2014
Summary
FDA records medical device Class II recall Z-0827-2015, published December 24, 2014 and initiated October 23, 2014. Recalling firm: JAS Diagnostics Inc.; Status: Terminated; Reported quantity: 390; Lot: Lot: N0702011K, Exp. 10/2014; N0702012, Exp. 10/2014; N0702013K, Exp. 10/2014; P010201K, Exp. 04/2015; P010202K, Exp. 04/2015; P010203K, Exp. 04/2015; P010204K, Exp. 04/2015; P010205K, Exp. 04/2015; P010206K, Exp. 04/2015; P0402015K, Exp. 07/2015; P0402016K, Exp. 07/2015; P050207K, Exp. 08/2015; P050208K, Exp. 08/2015; P050209K, Exp. 08/2015; P0502010K, Exp. 08/2015; P0502011K, Exp. 08/2015; P0502012K, Exp. 08/2015; P0502013K, Exp. 08/2015; P0502014K, Exp. 08/2015; and P0802017K, Exp. 11/2015. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Product is not performing according to specifications. Control 2 does not consistently recover within its assigned range.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- JAS Diagnostics Inc.
- Distributor
- Worldwide Distribution -- US, including the states of NV, TN, TX, FL, GA, NY, NC, CA, MN, OR and Puerto Rico; and, the countries of France, Jamaica, Haiti, Cayman Islands, Trinidad & Tobago, and Ghana.
- Lot
- Lot: N0702011K, Exp. 10/2014; N0702012, Exp. 10/2014; N0702013K, Exp. 10/2014; P010201K, Exp. 04/2015; P010202K, Exp. 04/2015; P010203K, Exp. 04/2015; P010204K, Exp. 04/2015; P010205K, Exp. 04/2015; P010206K, Exp. 04/2015; P0402015K, Exp. 07/2015; P0402016K, Exp. 07/2015; P050207K, Exp. 08/2015; P050208K, Exp. 08/2015; P050209K, Exp. 08/2015; P0502010K, Exp. 08/2015; P0502011K, Exp. 08/2015; P0502012K, Exp. 08/2015; P0502013K, Exp. 08/2015; P0502014K, Exp. 08/2015; and P0802017K, Exp. 11/2015.
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDADrew Scientific DREW 3-PAC Reagent Kit containing: 5L Diluent, 750 mL Enzymatic Cleaner, and 125 mL LysingJuly 12, 2017
- FDAWECK Hemoclip® Traditional Medium Tantalum Ligating Clips. Weck Ligating Clips are intended for use inDecember 24, 2014
- FDARESTORIS PST Straight Shell Inserter An impactor is a reusable instrument designed for use by orthopedicDecember 24, 2014
- FDACeramic Femoral Head. Intended for use in total hip arthroplasty applications to replace the articular surfaceDecember 24, 2014
- FDARESTORIS PST Acetabular Straight Shell Impactors An impactor is a reusable instrument designed for use byDecember 24, 2014
- FDAGlucose Hexokinase Liquid Reagent For the in vitro quantitative determination of Glucose in serum.July 2, 2014
Questions about this recall
Was Glucose Hexokinase (Liquid) Reagent For the in vitro quantitative determination of Glucose in serum. recalled?
Yes. FDA published recall Z-0827-2015 on December 24, 2014. Reported hazard: Product is not performing according to specifications. Control 2 does not consistently recover within its assigned range.
What should I do if I have this product?
Voluntary: Firm initiated · Letter